Cite
HARVARD Citation
Rathore, Y. et al. (2022). Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patients. Nuclear medicine communications. 43 (4), pp. 458-467. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rathore, Y. et al. (2022). Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patients. Nuclear medicine communications. 43 (4), pp. 458-467. [Online].